Tel: 1-631-504-6093
Awesome Features1111

Ten Cancer Drugs That “Made Headlines” in 2017

With upgrading of technologies and better understanding of diseases, the death rate caused by cancers is considerably decreased. According to the 2017 Cancer Progress Report released by the American Association […]

Read More →

FDA Approves Neratinib for Extended Adjuvant Treatment of Breast Cancer

On July 17, 2017, the U.S. Food and Drug Administration approved neratinib (Nerlynx, Puma Biotechnology, Inc.) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer to […]

Read More →